Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / American Depositary Shares, each representing one ordinary share
-
Shares outstanding
-
40,291,821
-
Total 13F shares
-
9,485,402
-
Share change
-
-231,929
-
Total reported value
-
$9,148,082
-
Price per share
-
$0.97
-
Number of holders
-
14
-
Value change
-
-$234,186
-
Number of buys
-
4
-
Number of sells
-
7
Institutional Holders of Barinthus Biotherapeutics plc. - American Depositary Shares, each representing one ordinary share (BRNS) as of Q1 2025
As of 31 Mar 2025,
Barinthus Biotherapeutics plc. - American Depositary Shares, each representing one ordinary share (BRNS) was held by
14 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
9,485,402 shares.
The largest 10 holders included
M&G PLC, Alphabet Inc., HSG Holding Ltd, DC Funds, LP, GILEAD SCIENCES, INC., Johns Hopkins University, Baird Financial Group, Inc., HighTower Advisors, LLC, RENAISSANCE TECHNOLOGIES LLC, and CITADEL ADVISORS LLC.
This page lists
14
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.